Floatz logo

CARVEDILOL

Left Ventricular Diastolic Dysfunction

Post Graduate Institute of Medical Education and Research, ChandigarhSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Left Ventricular Diastolic Dysfunction cohort.

Asset / SponsorPhaseRating
Semaglutide
Mayo Clinic
Phase 4BBB
Metformin
Sara ElAdawy
Phase 4BBB
Tirzepatide
Yunlong Wang
Phase 4BBB
Liraglutide
Leiden University Medical Center
Phase 4BBB
BENZBROMARONE
National Defense Medical Center, Taiwan
Phase 4BB

View all 23 →

Same molecule, other indications

CARVEDILOL is also rated in:

portal hypertensionDormant
BBB
Indicative ·
76 / 100
View asset →
esophageal varicesDormant
BBB
Indicative ·
73 / 100
View asset →
cirrhosis of liverDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →